FDA central management functions to receive $7.8 mil. from user fees in FY '97 -- Senate cmte..
Executive Summary
FDA POLICY AND MANAGEMENT FUNCTIONS WILL USE $7.8 MIL. IN USER FEES during fiscal 1997, according to the Senate Appropriations Committee report on the appropriations bill for FDA and related agencies adopted by a 26-0 vote July 11. The committee report for the first time breaks out the funding levels for FDA's offices of the commissioner, policy, external affairs, and management and systems as well as orphan product and other extramural grants and central services. The total cost of those activities in fiscal 1997 is budgeted at $113.8 mil., with $7.8 mil. paid for from prescription drug and mammography user fees, the report states.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth